SureSelect Human All Exon Kits
Agilent SureSelect All Exon kits are the most widely used target enrichment solution for exome sequencing. SureSelect Human All Exon V5 (targeting coding regions only) and V5+UTRs (targeting coding regions plus UTRs) have been updated to provide the greatest sequencing efficiency and enable samples ready for sequencing the next day. Greater coverage with less sequencing for lower overall costs – up to 60% less sequencing than…
Receive your quote directly from the manufacturer.
Agilent SureSelect All Exon kits are the most widely used target enrichment solution for exome sequencing. SureSelect Human All Exon V5 (targeting coding regions only) and V5+UTRs (targeting coding regions plus UTRs) have been updated to provide the greatest sequencing efficiency and enable samples ready for sequencing the next day.
Greater coverage with less sequencing for lower overall costs – up to 60% less sequencing than other exomes
Samples ready for sequencing the next day – short 16 hour overnight hybridization
Fast turnaround time for your exome projects – the most samples per sequencing run
Mutational Analysis of BRCA1/2 in Ovarian Cancer Patients
At the European Society of Human Genetics (ESHG) conference 2019, Dr. Bartosz Wasag, Medical University of Gdansk & University Clinical Centre, Gdansk, Poland, presents a cost-effective, highly-sensitive approach for the analysis of variants in breast and ovarian cancer-associated BRCA1 and BRCA2 genes. Using amplicon-based next-generation sequencing (NGS) technology from Agilent Technologies, this approach may be applicable for routine diagnostics in the future.
What Not to Miss at ASHG 2015
Highlights from the show, to be held on October 6-10, in Baltimore, MD, USA
Agilent Technologies to Showcase NGS Workflow Solutions at ASHG 2015
Visit booth #701 to discover more about Agilent’s innovative products for genetic analysis
